Profile Details

Create Project

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Hire Dr. Dominik C.

Poland

Biomedical researcher with experience in IP, technology trasfer and seed investment

Profile Summary

Experienced researcher in biochemistry and cancer research (Ph.D. from Jagiellonian University in Kraków, Poland). Previously involved in a number of research projects related to genetic engineering, medical biotechnology and cancer immunotherapy. Currently, an investment manager in a seed fund dealing with search & evaluation of early-stage investment opportunities in Poland and beyond.

Subject Matter Expertise

• ★ Biochemistry
• ★ Cancer Research
• ☆ Molecular Biology
• ☆ Biotechnology & Bioengineering
• ☆ Preclinical Research

Services

• Writing
• Research
• Data & AI

Writing Clinical Trial Documentation, Technical Writing

Research Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection

Data & AI Statistical Analysis

Work Experience

Investment manager

ABAN Fund

July 2018 - Present

Industrial Liaison Officer

Jagiellonian Centre for Experimental Therapeutics (Jagiellonian University in Krakow)

April 2016 - Present

Post-doctoral researcher, Academic teacher

Faculty of Biochemistry, Biophysics and Biotechnology (Jagiellonian University in Krakow)

December 2011 - September 2018

Technology Transfer Officer

CITTRU Centre for Innovation, Technology Transfer and University Development (Jagiellonian University in Krakow)

November 2008 - September 2012

Education

Ph.D. in biochemistry/cancer research

Faculty of Biochemistry, Biophysics and Biotechnology (Jagiellonian University in Krakow)

October 2003 - October 2008

M.Sc. in biotechnology

Faculty of Biotechnology (Jagiellonian University in Krakow)

October 1998 - June 2003

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Dominik Czaplicki, Tomasz Klaus, Krystyna Stalińska, Paweł Mak, Bozena Skupien-Rabian, Sylwia Kedracka-Krok, Karolina Wiatrowska, Monika Bzowska, Monika Machula, Joanna Bereta(2018). Mouse Antibody of {IgM} Class is Prone to Non-Enzymatic Cleavage between {CH}1 and {CH}2 Domains . Scientific Reports. 8. (1). Springer Nature